QTTB – q32 bio inc. (US:NASDAQ)
Stock Stats
News
Q32 Bio Inc. (NASDAQ: QTTB) was downgraded by analysts at BMO Capital Markets from an "outperform" rating to a "market perform" rating. They now have a $3.00 price target on the stock, down previously from $22.00.
Q32 Bio Inc. (NASDAQ: QTTB) was downgraded by analysts at Piper Sandler from an "overweight" rating to a "neutral" rating. They now have a $4.00 price target on the stock, down previously from $20.00.
Q32 Bio Announces Strategic Restructuring to Focus on Advancement of Bempikibart in Patients with Alopecia Areata [Yahoo! Finance]
Q32 Bio Announces Strategic Restructuring to Focus on Advancement of Bempikibart in Patients with Alopecia Areata
Q32 Bio to Participate in Oppenheimer's 35th Annual Healthcare Life Sciences Conference
Form SCHEDULE 13G/A Q32 Bio Inc. Filed by: BRISTOL MYERS SQUIBB CO
Form 424B3 Q32 Bio Inc.
Form 8-K Q32 Bio Inc. For: Feb 10
Form SCHEDULE 13G Q32 Bio Inc. Filed by: Sio Capital Management, LLC
Form 8-K Q32 Bio Inc. For: Jan 13
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.